The Advanced Research Projects Agency for Health (ARPA-H) is seeking unique and creative ideas on how to best collaborate with the FDA to encourage and incentivize public-private partnerships in the health ecosystem, with the goal of accelerating better health outcomes for everyone. Review the full Request for Information: Accelerating Innovation through ARPA-H and FDA Collaboration and instructions at

Further information and submission criteria are available at Topics of interest include:

  • New and innovative models to accelerate pre-competitive development of platform technologies to support downstream development of products resulting from those platform approaches in a disease agnostic manner.
  • Strategies to accelerate alternatives to traditional human or animal research for medical product development.
  • Case studies on the development of innovative technologies that highlight best practices for using existing FDA regulatory pathways.

Interested persons and organizations are invited to submit comments on or before May 30 by 5 p.m. ET. Early submissions are encouraged as materials will be reviewed on a rolling basis. Submit comments electronically to and include “RFI Response: Accelerating Innovation through ARPA-H and FDA Collaboration” in the subject line of the email.